NASH: Bridging the Gap Between Lifestyle Disease and Epidemic Status

Nonalcoholic Steatohepatitis (NASH) has swiftly evolved from a relatively unknown health concern to a major public health challenge, standing at the crossroads between a lifestyle-related disease and a growing global epidemic. A more severe form of nonalcoholic fatty liver disease (NAFLD), NASH is characterized by the buildup of fat in the liver accompanied by inflammation…

Unveiling NASH: Bridging Gaps in Awareness, Diagnosis, and Treatment

Nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease (NAFLD), has quietly become a global health concern. Characterized by fat accumulation in the liver, inflammation, and cellular damage, NASH can lead to fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Often asymptomatic in its early stages, the disease is frequently diagnosed too late,…

Decoding NASH: A Comprehensive Guide to Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH) is a serious and progressive liver disease that has been increasingly recognized as a major public health issue worldwide. Often referred to as the “silent liver disease,” NASH occurs in individuals who do not consume excessive amounts of alcohol but develop liver inflammation and fat buildup, leading to liver damage. This article…